Marinus Pharmaceuticals
Utility Patent Applications

Last updated:

List of all Marinus Pharmaceuticals patents 8 in total

Status Patent
Application
Utility: GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS External link
Filling date: 7 Sep 2025 Issue date: 25 Aug 2022
Application
Utility: GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS External link
Filling date: 7 Sep 2025 Issue date: 11 Aug 2022
Application
Utility: GANAXOLONE FOR USE IN TREATING TUBEROUS SCLEROSIS COMPLEX External link
Filling date: 7 Sep 2025 Issue date: 7 Jul 2022
Application
Utility: GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS External link
Filling date: 7 Sep 2025 Issue date: 24 Jun 2021
Application
Utility: INJECTABLE NEUROSTEROID FORMULATIONS CONTAINING NANOPARTICLES External link
Filling date: 7 Sep 2025 Issue date: 6 May 2021
Application
Utility: METHODS OF TREATING CERTAIN DEPRESSIVE DISORDERS AND DELIRIUM TREMENS External link
Filling date: 7 Sep 2025 Issue date: 17 Sep 2020
Application
Utility: GANAXOLONE FOR USE IN PROPHYLAXIS AND TREATMENT OF POSPARTUM DEPRESSION External link
Filling date: 7 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: METHOD OF ADMINISTERING A NEUROSTEROID TO EFFECT ELECTROENCEPHALOGRAPHIC (EEG) BURST SUPPRESSION External link
Filling date: 7 Sep 2025 Issue date: 24 Oct 2019

Showing 1 to 8 of 8 patents.